Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in ...

NDAA package revives stalled measures on US outbound investment and biotech, signalling Capitol Hill’s hardened stance ...

Eli Lilly invests $6 billion in new drug manufacturing facility in Alabama, designed to expanding U.S. production and strengthening medicine supply chains.

During a press conference held on Tuesday, pharmaceutical giant Eli Lilly announced that they will construct a $6 billion ...

Eli Lilly and Company announced Tuesday it was investing more than $6 billion in a new manufacturing facility in Huntsville, ...

Photoactive nanomaterials represent a dynamic and rapidly evolving area within nanobiotechnology, offering unique opportunities to manipulate cellular and ...

Butani and Yu were two of the 43 recipients of the 2025 Marshall Scholarship, which funds two years of study in the United ...

The US Congress is set to vote, could happen this week, on the 2025 National Defense Authorization Act (NDAA), a "must-pass" ...

Allied Market Research published a report, titled, "Immunostimulant Market by Product Type (Vaccines, Colony Stimulating ...

Enveric Biosciences ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today ...

The first tranche of startup applications under the RDI scheme is expected by March 2026, following approvals for Birac and ...

The incidence of HPV16-related cancers is rapidly increasing in the US and Europe and also increasing globally.* PDS0101 is currently being studied in the Company’s Phase 3 trial for PDS0101 + ...